Shares of Merck gain on COVID-19 research collaboration [MarketWatch]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: MarketWatch
Shares of Merck & Co. Inc. gained 1.9% in premarket trading on Monday after the drugmaker announced a COVID-19 collaboration with the Institute for Systems Biology (IBS), a research organization. The aim, they said, is to identify molecular mechanisms of infections caused by the novel coronavirus. Merck said it is has received funding from the Biomedical Advanced Research and Development Authority to support the research. As part of a scientific trial included in the collaboration, researchers plan to analyze blood samples and nasal swabs of 200 patients who have tested positive for COVID-19 and are being cared for at Swedish Medical Center in Seattle by collecting them several times. The ISB and Swedish Medical Center are both part of the Providence St. Joseph Health hospital system. "Understanding the molecular characteristics of SARS-CoV-2 infection, and of the immune response to this virus, is essential to the development of effective interventions," Dr. Roger Perlmutter, presiden
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck Trials, Tempus AI Deal And Leadership Shifts Shape Valuation Story [Yahoo! Finance]Yahoo! Finance
- Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial [Yahoo! Finance]Yahoo! Finance
- Akeso Deepens Cadonilimab Story With Survival Data And Global GBM Trial [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Evaxion announces business update and full year 2025 financial results [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/24/26 - Form 10-K
- 2/17/26 - Form 13F-HR
- 2/13/26 - Form 144/A
- MRK's page on the SEC website